Medica moves into global clinical trials market with US acquisition

Dr Stuart Quin, chief executive officer, Medica Group

London listed teleradiology provider Medica Group has agreed to acquire US-based imaging contract research organisation (iCRO) RadMD, paving its way for entry into the $1bn global clinical trial imaging market. The acquisition price of up to $21.7m (c. £15.6m) comprises an initial cash consideration of $16.3m and deferred consideration of up to $5.4m based on the company’s…

You must be a HM Subscriber to view this content.

Subscribe Now »